The role of hepatic enzymes in Crohn’s disease

The role of hepatic enzymes in Crohn’s disease Int J Colorectal Dis (2017) 32:1363–1364 DOI 10.1007/s00384-017-2829-1 LETTER TO THE EDITOR 1 1 2 Davide Giuseppe Ribaldone & Marco Astegiano & Rinaldo Pellicano Accepted: 27 April 2017 /Published online: 4 May 2017 Springer-Verlag Berlin Heidelberg 2017 Dear Editor: A recent interesting retrospective study was performed in A systematic review has reported that, in Crohn’sdis- 383 newly diagnosed (not treated) CD patients. One patient ease (CD) patients, the prevalence of cholelithiasis ranged with chronic liver disease (small-duct PSC) was excluded. Of from 11 to 34%, that of primary sclerosing cholangitis the 383 patients included in this study, 131 had liver test ab- normalities (34.1%), but liver diseases were not found, apart (PSC) from 1.2 to 3.4%, that of fatty liver disease 23%, and hepatic amyloidosis occurred in <1% [1]. In a prospec- from liver steatosis in 6% of patients [3](versus 29%in the tive, single-blind study, we evaluated the prevalence of previous study [2]). histological changes in the liver of patients with CD, with- The two studies [2, 3] agree that, considering the out alterations of both liver biochemical tests and ultra- cost/benefit ratio, patients with CD should be considered as sound, and their prognostic significance. The patients healthy from http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Colorectal Disease Springer Journals

The role of hepatic enzymes in Crohn’s disease

Loading next page...
 
/lp/springer_journal/the-role-of-hepatic-enzymes-in-crohn-s-disease-ebtVWv06SE
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Surgery; Internal Medicine; Gastroenterology; Hepatology; Proctology
ISSN
0179-1958
eISSN
1432-1262
D.O.I.
10.1007/s00384-017-2829-1
Publisher site
See Article on Publisher Site

Abstract

Int J Colorectal Dis (2017) 32:1363–1364 DOI 10.1007/s00384-017-2829-1 LETTER TO THE EDITOR 1 1 2 Davide Giuseppe Ribaldone & Marco Astegiano & Rinaldo Pellicano Accepted: 27 April 2017 /Published online: 4 May 2017 Springer-Verlag Berlin Heidelberg 2017 Dear Editor: A recent interesting retrospective study was performed in A systematic review has reported that, in Crohn’sdis- 383 newly diagnosed (not treated) CD patients. One patient ease (CD) patients, the prevalence of cholelithiasis ranged with chronic liver disease (small-duct PSC) was excluded. Of from 11 to 34%, that of primary sclerosing cholangitis the 383 patients included in this study, 131 had liver test ab- normalities (34.1%), but liver diseases were not found, apart (PSC) from 1.2 to 3.4%, that of fatty liver disease 23%, and hepatic amyloidosis occurred in <1% [1]. In a prospec- from liver steatosis in 6% of patients [3](versus 29%in the tive, single-blind study, we evaluated the prevalence of previous study [2]). histological changes in the liver of patients with CD, with- The two studies [2, 3] agree that, considering the out alterations of both liver biochemical tests and ultra- cost/benefit ratio, patients with CD should be considered as sound, and their prognostic significance. The patients healthy from

Journal

International Journal of Colorectal DiseaseSpringer Journals

Published: May 4, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off